… The Epicyte scientists went one step further and created the ultimate GM crop—‘contraceptive corn’—after researchers discovered a rare class of human antibodies that attack sperm. By isolating the genes that regulate the manufacture of these antibodies, and by putting them in corn plants, the company has created tiny horticultural factories that make contraceptives.
Announcing his success at a 2001 press conference, the president of Epicyte, Mitch Hein, pointing to his GMO corn plants and announced, “We have a hothouse filled with corn plants that make anti-sperm antibodies.”
HEIN EXPLAINED that they had taken antibodies from women with a rare condition known as immune infertility, isolated the genes that regulated the manufacture of those infertility antibodies, and, using genetic engineering techniques, had inserted the genes into ordinary corn seeds. In this manner they have produced a hidden contraceptive embedded in corn meant for human consumption.
“If the men eat the epicyte gene they produce antibodies to
their own sperm, rendering them irreversibly sterile.”
“Essentially, the antibodies are attracted to surface receptors on the sperm,” said Hein. “They latch on and make each sperm so heavy it cannot move forward. It just shakes about as if it was doing the lambada.” Hein claimed it was a possible solution to world “over-population.” …
Shortly after the 2001 Epicyte press release, all discussion of the breakthrough vanished. The company itself was taken over in 2004 by Biolex and nothing more was heard in any media about the development of spermicidal corn. …
2:52p CT Thursday, October 25, 2012
GoldMoney founder and GATA consultant James Turk, whose 2001 commentary first posted at his Free Gold Money Report Internet site, “Behind Closed Doors” —
— and republished at GATA’s Internet site —
— martialed the evidence that the United States had swapped gold with the German Bundesbank for market-rigging purposes, today tells King World News that all the German gold vaulted abroad has been gone, leased into the market, for 11 years. Excerpts from the interview and Turk’s 2001 commentary are posted at the King World News blog here:
Clenora Hudson-Weems, Ph.D., was the first to establish the position of the August 28, 1955, brutal lynching of Emmett Louis Till, the 14-year-old Black Chicago youth, for whistling at a 21-year-old white woman (Carolyn Bryant) in Money, MS, as the catalyst of the Modern Civil Rights Movement. In her 1988 doctoral dissertation, ‘Emmett Till: The Impetus for the Modern Civil Rights Movement’ (U. of Iowa), later published as Emmett Till: The Sacrificial Lamb of the Civil Rights Movement (1994), she carefully documents the Till murder case as having set the stage for the 1956 Montgomery Bus Boycott, since it happened 3 months and 3 days before Rosa Parks refused to give up her seat to a white man on a Montgomery bus, December 1, 1955. A Ford Fellow, she quests for truth surrounding the underplaying of the case in American history, concluding that Parks’ demonstration was more palatable than Till’s bloated face, in spite of King’s assertion in Stride Toward Freedom that pressed in the minds of the Alabamians during the boycott was the image of Till. Contending that ‘Historians will talk about the good and the bad, but they won’t deal with the ugly …’
She’s recently completed a screenplay for an upcoming hollywood film, I’ve read part of it. She has an oscar-winning director and actors working with her. It will get an oscar if they do it justice.
This isn’t real medicine they’re talking about: it’s just another handout to the financial sector. If you couldn’t afford eugenical rockefeller medicine before obamacare you’re certainly not going to be able to afford it after it becomes compulsory and beyond competition from real alternatives. Being poor is about to become outright illegal in this country. The simple alternative of medicare for all would have been honest. It works and it’s cheap because it bypasses wall street.
Obama has certainly turned out to be a good investment for his primary 2008 campaign contributor, goldman sachs.